| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/04/2023 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 2.6k | $37.21 | $95.8k | | 01/04/2023 |
| 01/01/2023 | Intellia Therapeutics, Inc. | NTLA | Exercise | Restricted Stock Unit | 3.2k | $0.00 | $0 | | 01/01/2023 |
| 03/01/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 20.2k | $79.85 | $1.6M | | 03/01/2022 |
| 03/01/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 13.8k | $79.85 | $1.1M | | 01/01/2022 |
| 03/01/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | | 13.8k | $0.00 | $0 | | 01/01/2022 |
| 01/01/2022 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 1.1k | $112.24 | $118k | | 01/01/2022 |
| 01/01/2022 | Intellia Therapeutics, Inc. | NTLA | Exercise | Restricted Stock Unit | 3.2k | $0.00 | $0 | | 01/01/2022 |
| 11/05/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 452 | $132.62 | $59.9k | | 11/05/2021 |
| 11/05/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 548 | $134.07 | $73.5k | | 11/05/2021 |
| 11/05/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 200 | $135.34 | $27.1k | | 11/05/2021 |
| 11/05/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 2.4k | $12.62 | $30.3k | | 11/05/2021 |
| 11/05/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 1.2k | $131.71 | $158.1k | | 11/05/2021 |
| 10/14/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 2.4k | $12.62 | $30.3k | | 10/14/2021 |
| 10/14/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 250 | $130.47 | $32.6k | | 10/14/2021 |
| 10/14/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 525 | $129.83 | $68.2k | | 10/14/2021 |
| 10/14/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 225 | $129.01 | $29k | | 10/14/2021 |
| 10/14/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 849 | $127.81 | $108.5k | | 10/14/2021 |
| 10/14/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 551 | $126.92 | $69.9k | | 10/14/2021 |
| 09/24/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 7.9k | $12.62 | $100k | | 09/24/2021 |
| 09/21/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 2.4k | $149.81 | $359.5k | | 09/21/2021 |
| 09/21/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 2.4k | $12.62 | $30.3k | | 09/21/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 150 | $160.10 | $24k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 200 | $155.43 | $31.1k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 2.4k | $12.62 | $30.3k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 1.1k | $159.19 | $175.1k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 250 | $157.60 | $39.4k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 700 | $156.70 | $109.7k | | 08/30/2021 |
| 08/09/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 2.4k | $164.05 | $393.7k | | 08/09/2021 |
| 08/09/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 2.4k | $12.62 | $30.3k | | 08/09/2021 |
| 03/03/2021 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 76.5k | $57.71 | $4.4M | | 03/03/2021 |
| 03/03/2021 | Intellia Therapeutics, Inc. | NTLA | Grant | Restricted Stock Unit | 12.8k | $0.00 | $0 | | 03/03/2021 |
| 05/01/2020 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (Right to Buy) | 200k | $12.62 | $2.5M | | 05/01/2020 |